Endocrinology Drugs Flashcards
Insulin examples
Insulin aspart, insulin glargine, biphasic insulin, soluble insulin
Insulin indications
- Insulin replacement in TI DM
- Control of blood glucose in TII DM where oral hypoglycaemics inadequate / poorly tolerated
- IV in diabetic emergencies e.g. DKA, hyperglycaemic hyperosmolar syndrome
- Hyperkalaemia: alongside glucose while underlying cause investigated
Insulin MOA
Comes in rapid, short, intermediate, long acting and biphasic forms.
DM: works in similar way to endogenous insulin.
- Increases glucose uptake
- Increases use of glucose as energy
- Stimulates glycogen, lipid and protein synthesis
- Inhibits gluconeogenesis and ketogenesis
Hyperkalaemia: drives K+ into cells. Only short-term as leaks out again once stopped.
NB: biphasic insulin contains mixture of rapid and intermediate acting. Number in name indicates % short-acting
Insulin administration
SC: self-administered
IV in diabetic emergencies
Insulin contrainidactions
Higher risk of hypoglycaemia in renal failure as clearance reduced
Insulin side effects
Hypoglycaemia: coma and death
Lipid overgrowth at SC injection site
Insulin interactions
- Hypoglycaemic agents: increased risk hypoglycaemia
2. Corticosteroids: increases requirements
Gliclazide class
Sulphonylureas
Gliclazide indications
- TII DM: single agent to control blood glucose and reduce complications where metformin contraindicated or not tolerated
- TII DM in combination with metformin where glucose not adequately controlled
Gliclazide MOA
- Stimulates pancreatic insulin secretion
- Block ATP dependent K+ channels in beta-cell membranes
- Causes depolarisation of cell and opening of voltage gated Ca2+
- Increases intracellular Ca2+
- Stimulates insulin secretion
- Only useful in pts with residual pancreatic function.
- Insulin anabolic hormone - causes weight gain
- Weight gain increases insulin resistance, can worsen DM in long term
Gliclazide contraindications
- Hepatic / renal impairment: dose reduction
- Caution in those at risk of hypoglycaemia
Gliclazide side effects
Dose-related: Infrequent but include nausea, vomiting, diarrhoea and constipation.
Hypoglycaemia: caution in high doses / combination.
Hypersensitivity: rare but include hepatic toxicity, drug hypersensitivity syndrome, haematological abnormalities
Gliclazide interactions
- Other hypoglycaemic agents
- Efficacy reduced by drugs which elevate glucose: prednisolone, thiazide / loop diuretics
Gliclazide patient info
Take with meals
Metformin class
biguanides
Metformin MOA
- Lowers blood glucose by increasing sensitivity to insulin.
- Suppresses hepatic glucose production .- glycogenolysis and gluconeogenesis
- Increases glucose uptake and utilisation by skeletal muscle and suppresses intestinal glucose absorption
- Does not stimulate pancreatic insulin secretion and therefore does not cause hypoglycaemia
- Reduces weight gain and can induce weight loss - prevents worsening of insulin resistance
Metformin indications
TII DM: 1st line for controlling blood glucose. Alone or combination.